x

RSS Newsfeeds

See all RSS Newsfeeds

Apr 21, 2017 5:55 AM ET

-Acute Heart Failure (AHF) Therapeutics – Global Strategic Business Report 2017 – Conventional Therapies Leave Considerable Unmet Needs

iCrowdNewswire - Apr 21, 2017

M2 PRESSWIRE-April 21, 2017-Acute Heart Failure (AHF) Therapeutics – Global Strategic Business Report 2017 – Conventional Therapies Leave Considerable Unmet Needs
(C)1994-2017 M2 COMMUNICATIONS

RDATE:21042017

Dublin – Research and Markets has announced the addition of the “Acute Heart Failure (AHF) Therapeutics – Global Strategic Business Report” report to their offering.

This report analyzes the worldwide markets for Acute Heart Failure (AHF) Therapeutics in US$ Thousand. The report provides separate comprehensive analytics for the US, Japan, Europe, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022. Market data and analytics are derived from primary and secondary research.

The report profiles 34 companies including many key and niche players such as:

– Bayer AG (Germany)
– Bristol-Myers Squibb Company (USA)
– Cardiorentis AG (Switzerland)
– CVie Therapeutics Limited (Taiwan)
– Cytokinetics, Inc. (USA)
– Merck & Co. (USA)
– Novartis AG (Switzerland)
– Orion Corporation (Finland)
– PhaseBio Pharmaceuticals, Inc. (USA)

Key Topics Covered:

1. INDUSTRY OVERVIEW

2. MARKET DRIVERS, TRENDS & ISSUES

3. TREATMENT OF ACUTE HEART FAILURE (AHF)

4. ACUTE HEART FAILURE – THE DISEASE, CAUSES, SYMPTOMS, AND EVALUATION METHODS

5. RECENT INDUSTRY ACTIVITY

6. FOCUS ON SELECT PLAYERS

7. GLOBAL MARKET PERSPECTIVE

Total Companies Profiled: 34 (including Divisions/Subsidiaries – 35)

– The United States (18)
– Japan (2)
– Europe (10)

– Germany (2)
– The United Kingdom (2)
– Italy (1)
– Rest of Europe (5)

– Asia-Pacific (Excluding Japan) (5)

For more information about this report visit http://www.researchandmarkets.com/research/hg72ll/acute_heart

Contact Information:

Research and Markets,
Laura Wood,
Senior Manager.
[email protected]
Fax from USA: 646-607-1907
Fax from rest of the world: +353-1-481-1716
Related Topics: Cardiovascular Drugs (http://www.researchandmarkets.com/categories.asp?cat_id=116&campaign_id=hg72ll), Cardiology (http://www.researchandmarkets.com/categories.asp?cat_id=965&campaign_id=hg72ll)


((M2 Communications disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.m2.com on the world wide web. Inquiries to [email protected])).

Via iCrowdNewswire
Tags: , M2 Presswire, Wire
View Related News >
support